Chengdu Easton Biopharmaceuticals Co., Ltd. Class ASSE: 688513

"Chengdu Easton Bio Pharmaceuticals Co., Ltd."Announcement on the Voluntary Disclosure of Obtaining Drug Registration Certificate for Remimazolam Besylate for Injection

· Issued by Chengdu Easton Biopharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Voluntary Disclosure of Obtaining Drug Registration Certificate for Remimazolam Besylate for Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis